e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Blood eosinophils and more in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
R. Dhar (Kolkata, India), S. Chhowala (Mumbai, India), M. Lopez (Mumbai, India), R. Hegde (Mumbai, India), S. Madas (Pune, India), S. Salvi (Pune, India), J. Gogtay (Mumbai, India)
Source:
International Congress 2019 – Blood eosinophils and more in airway diseases
Session:
Blood eosinophils and more in airway diseases
Session type:
Oral Presentation
Number:
3562
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Dhar (Kolkata, India), S. Chhowala (Mumbai, India), M. Lopez (Mumbai, India), R. Hegde (Mumbai, India), S. Madas (Pune, India), S. Salvi (Pune, India), J. Gogtay (Mumbai, India). Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?. 3562
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
Late Breaking Abstract - Transcriptomic Profiling of Severe Asthma using Artificial Intelligence techniques
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018
Late Breaking Abstract - Severe Asthma Prevalence, Care Pathways, and Health Care Resource Utilization in France
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
How to Manage Severe Asthma, the Value of Inflammation Monitoring
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Late Breaking Abstract - Influence of Weather Conditions on the Onset of Primary Spontaneous Pneumothorax: Positive Association with Occurrence of “clusters”
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017
Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement?
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019
Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020
Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Late Breaking Abstract - A Deep Learning Algorithm for Classifying Fibrotic Lung Disease on High Resolution Computed Tomography
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease?
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Problems of Importance in Severe Asthma: A Patient Perspective
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019
Late Breaking Abstract - Abdominal Muscle Function During Spontaneous Breathing Trials to Predict Extubation Failure
Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation
Year: 2020
High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept